Pharming Group NV PHARM-NL:Euronext Amsterdam

*Data is delayed | EUR
Last | 03/05/21 CET
1.09UNCH (UNCH)
52 week range
0.75 - 1.50

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.09
  • 52 Week High1.50
  • 52 Week High Date12/22/20
  • 52 Week Low0.75
  • 52 Week Low Date03/23/20
  • Market Cap833.82M
  • Shares Out638.82M
  • 10 Day Average Volume9.76M
  • Dividend-
  • Dividend Yield-
  • Beta1.72
  • 1 Year % Change-5.21

RATIOS/PROFITABILITY

  • EPS (TTM)0.05
  • P/E (TTM)21.42
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Pharming Group NV News

There is no recent news for this security.

Latest PHARM-NL News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1...
Jeroen Wakkerman
Chief Financial Officer
Address
Darwinweg 24
Leiden
2333 CR
Netherlands